Biomarkers and diagnostics play a critical role in fulfilling the promise of precision medicine. In modern medicine, diagnostics are not only used to diagnose disease, but to identify those patients who are most likely to respond to targeted therapies, monitor treatment response, and provide insight into disease drivers and potential drug targets.

Moreover, the emergence of the global pandemic-and the subsequent boom in diagnostic development-indisputably demonstrated the importance of diagnostics to protecting population health.

In this e-Book, we explore timely topics in the diagnostics landscape, from regulatory considerations and next-generation COVID-19 diagnostics to an innovative next-generation sequencing initiative that will help fuel the next wave of biomarker-driven research and development.

As a precision medicine clinical research organization, Precision for Medicine has brought together new technologies, expertise and operational scale to help the life sciences industry improve the speed, cost and success rate of bringing life-changing therapies to patients.

Our unmatched experience in diagnostics spans the spectrum from preclinical development to product launch and market access, with more than 500 trials conducted for IVDs, CDx, and therapeutics, and more than 250 marketing clearances and approvals for IVD submissions.